UL Solutions Financial Ratios
NYSE: ULSHealth CarePrecision InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
UL Solutions ratio analysis
UL Solutions earned a net margin of 10.6% in FY 2025, down from 11.4% a year earlier. Gross margin was 49.5% compared with a median of 47.9% over the prior 3 years. Return on equity reached 25.8%, meaning UL Solutions generated 0.26 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.39 versus 0.82 the year before, and the current ratio was 1.32. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
UL Solutions financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 50.57 | 30.44 | — | — |
| Price / sales | 5.33 | 3.44 | — | — |
| Price / book | 12.89 | 10.91 | — | — |
| Gross margin | 49.5% | 48.5% | 47.9% | 47.9% |
| Operating margin | 17.1% | 16.1% | 13.7% | 16.3% |
| Net margin | 10.6% | 11.4% | 9.7% | 11.6% |
| Free cash flow margin | 13.2% | 10.0% | 9.4% | 8.3% |
| Return on equity (ROE) | 25.8% | 36.1% | 39.8% | 27.2% |
| Return on assets (ROA) | 11.1% | 11.6% | 9.5% | — |
| Debt / equity | 0.39 | 0.82 | 1.38 | — |
| Current ratio | 1.32 | 1.24 | 1.34 | — |
| Revenue growth | 6.4% | 7.2% | 6.3% | — |
| EPS growth | -1.2% | 24.6% | -11.6% | — |